Cellero to Join Charles River

We have exciting news!

On August 5, 2020, Cellero announced that we will officially be joining Charles River.

This change complements Charles River’s recent acquisition of HemaCare and will allow our company to better serve our customers and partners across the cell and gene therapy lifecycle.

This unified organization will enhance the supply of critical biomaterials, including a wide range of human-derived primary cell types to support the discovery, development, and manufacture of cell therapies.

Together we can help more people on their journeys to health and wellness.

This post originally appeared on the Cellero blog and has been modified for Patch.